Profile
Full Name
Sangamo Therapeutics, Inc.Ticker Symbol
SGMOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 6, 2000Indexes
Not includedWebsite
http://www.sangamo.comEmployees
183Key Details
Price
$0.71(+2.90%)
Market cap
$159.54M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$57.80M(-67.20% YoY)
Annual EPS
-$0.49(+66.89% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Sangamo Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 7, 25 HC Wainwright & Co.
BuyMar 18, 25 RBC Capital
Sector PerformJan 27, 25 HC Wainwright & Co.
BuyJan 23, 25 Truist Securities
BuyJan 2, 25 HC Wainwright & Co.
BuyDec 31, 24 Wells Fargo
Equal-WeightDec 31, 24 Jefferies
BuyDec 20, 24 HC Wainwright & Co.
BuyDec 19, 24 HC Wainwright & Co.
BuyDec 10, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Sangamo Therapeutics?
- Does Sangamo Therapeutics pay dividends?
- What sector is Sangamo Therapeutics in?
- What industry is Sangamo Therapeutics in?
- What country is Sangamo Therapeutics based in?
- When did Sangamo Therapeutics go public?
- Is Sangamo Therapeutics in the S&P 500?
- Is Sangamo Therapeutics in the NASDAQ 100?
- Is Sangamo Therapeutics in the Dow Jones?
- When was Sangamo Therapeutics's last earnings report?
- When does Sangamo Therapeutics report earnings?
- Should I buy Sangamo Therapeutics stock now?
What is the ticker symbol for Sangamo Therapeutics?
The ticker symbol for Sangamo Therapeutics is NASDAQ:SGMO
Does Sangamo Therapeutics pay dividends?
No, Sangamo Therapeutics does not pay dividends
What sector is Sangamo Therapeutics in?
Sangamo Therapeutics is in the Healthcare sector
What industry is Sangamo Therapeutics in?
Sangamo Therapeutics is in the Biotechnology industry
What country is Sangamo Therapeutics based in?
Sangamo Therapeutics is headquartered in United States
When did Sangamo Therapeutics go public?
Sangamo Therapeutics's initial public offering (IPO) was on April 6, 2000
Is Sangamo Therapeutics in the S&P 500?
No, Sangamo Therapeutics is not included in the S&P 500 index
Is Sangamo Therapeutics in the NASDAQ 100?
No, Sangamo Therapeutics is not included in the NASDAQ 100 index
Is Sangamo Therapeutics in the Dow Jones?
No, Sangamo Therapeutics is not included in the Dow Jones index
When was Sangamo Therapeutics's last earnings report?
Sangamo Therapeutics's most recent earnings report was on Mar 17, 2025
When does Sangamo Therapeutics report earnings?
The next expected earnings date for Sangamo Therapeutics is May 9, 2025
Should I buy Sangamo Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions